We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 2,137 results
  1. Patients with obesity have more inflamed joints and higher CRP levels during the disease course in ACPA-positive RA but not in ACPA-negative RA

    Background

    Obese RA patients have higher disease activity scores (DAS). Previous research showed that obese RA patients have higher tender joint count...

    N. K. den Hollander, A. M. P Boeren, ... H. W. van Steenbergen in Arthritis Research & Therapy
    Article Open access 07 February 2024
  2. Lipoxygenase-derived oxylipins are enriched in anti-citrullinated protein antibody (ACPA)-positive individuals at risk for develo** rheumatoid arthritis

    Background

    Rheumatoid arthritis (RA) is typically preceded by an extended preclinical period where circulating autoantibodies, particularly...

    Liam J. O’Neil, Vidyanand Anaparti, ... Hani El-Gabalawy in Arthritis Research & Therapy
    Article Open access 15 February 2024
  3. Body mass index stratification enables cytokine-based prediction of ACPA status and Power-Doppler disease activity in rheumatoid arthritis

    Objective

    Rheumatoid arthritis can be classified according to ACPA and RF status. ACPA status may be associated with other pathophysiological...

    O. Gadeholt, E. Arnold, ... W. Arnold in Clinical Rheumatology
    Article 14 June 2024
  4. Can ACPA protect against RA?

    Robert Phillips in Nature Reviews Rheumatology
    Article 05 April 2023
  5. Comparative effectiveness of abatacept versus TNF inhibitors in rheumatoid arthritis patients who are ACPA and shared epitope positive

    Background

    The HLA-DRB1 shared epitope (SE) is a risk factor for the development of rheumatoid arthritis (RA) and the production of...

    Leslie R. Harrold, Keith Wittstock, ... Vadim Khaychuk in Advances in Rheumatology
    Article Open access 19 January 2024
  6. Immunoprofiling of early, untreated rheumatoid arthritis using mass cytometry reveals an activated basophil subset inversely linked to ACPA status

    Background

    Autoantibody production is a hallmark of rheumatoid arthritis (RA). Anti-citrullinated protein antibodies (ACPA) are highly...

    H. Koppejan, M. Hameetman, ... F. A. van Gaalen in Arthritis Research & Therapy
    Article Open access 29 October 2021
  7. Genetic variant in SPAG16 is associated with the susceptibility of ACPA-positive rheumatoid arthritis possibly via regulation of MMP-3

    Objectives

    In two previously published genome-wide association studies, a cluster of variants of sperm-associated antigen16 ( SPAG16 ) were reported to...

    Qingxi Lin, Bingxiang Zhou, ... **ng Wei in Journal of Orthopaedic Surgery and Research
    Article Open access 24 November 2022
  8. Unraveling heterogeneity within ACPA-negative rheumatoid arthritis: the subgroup of patients with a strong clinical and serological response to initiation of DMARD treatment favor disease resolution

    Background

    Rheumatoid arthritis (RA) is a heterogeneous disease, as evidenced by the differences in long-term outcomes. This applies especially to...

    M. Verstappen, H. W. van Steenbergen, ... A. H. M. van der Helm-van Mil in Arthritis Research & Therapy
    Article Open access 03 January 2022
  9. Differential Changes in ACPA Fine Specificity and Gene Expression in a Randomized Trial of Abatacept and Adalimumab in Rheumatoid Arthritis

    Introduction

    The biologics abatacept and adalimumab have different mechanisms of action (MoAs). We analyzed data from patients with rheumatoid...

    Omar Jabado, Michael A. Maldonado, ... Sean E. Connolly in Rheumatology and Therapy
    Article Open access 08 December 2021
  10. Distinctive Clinical Characteristics and Outcome of ILD-Onset Rheumatoid Arthritis and ACPA-Positive ILD: a Longitudinal Cohort of 282 Cases

    The aim of this study is to investigate the clinical features and outcome of interstitial lung disease (ILD)-onset rheumatoid arthritis (RA) and...

    Ru-Xuan Chen, Li-Dan Zhao, ... Xuan Zhang in Clinical Reviews in Allergy & Immunology
    Article 10 November 2020
  11. ACPA-positive versus ACPA-negative rheumatoid arthritis: two distinct erosive disease entities on radiography and ultrasonography

    The objective of this study is to assess the prevalence, localization, and severity of bone erosions on radiography (RX) and ultrasonography (US)...

    Julien Grosse, Edem Allado, ... Damien Loeuille in Rheumatology International
    Article 13 December 2019
  12. Potential alleviation of bone mineral density loss with Janus kinase inhibitors in rheumatoid arthritis

    Objective

    Rheumatoid arthritis (RA) is characterized by localized bone loss, general osteoporosis and increased fracture risks. Tumour necrosis factor...

    Yun-Wen Chen, Hsin-Hua Chen, ... Yi-Ming Chen in Clinical Rheumatology
    Article 02 September 2023
  13. Differential regulation and correlation between galectin-9 and anti-CCP antibody (ACPA) in rheumatoid arthritis patients

    Background

    Galectin-9 (Gal-9) is involved in the regulatory process of immune responses or inflammation. The aim of the present study is to...

    Yuya Fujita, Tomoyuki Asano, ... Kiyoshi Migita in Arthritis Research & Therapy
    Article Open access 15 April 2020
  14. Absence of Epstein-Barr virus DNA in anti-citrullinated protein antibody-expressing B cells of patients with rheumatoid arthritis

    Objective

    Rheumatoid arthritis (RA) is characterized by the presence of disease-specific autoreactive B cell responses, in particular those generating...

    Sanne Kroos, Arieke S. B. Kampstra, ... Hans U. Scherer in Arthritis Research & Therapy
    Article Open access 13 October 2022
  15. Benefits of Autoantibody Enrichment in Early Rheumatoid Arthritis: Analysis of Efficacy Outcomes in Four Pooled Abatacept Trials

    Introduction

    The efficacy of abatacept is enhanced in anti-citrullinated protein antibody (ACPA) and rheumatoid factor (RF)-positive versus -negative...

    Kaleb Michaud, Philip G. Conaghan, ... Janet Pope in Rheumatology and Therapy
    Article Open access 25 May 2023
  16. Radiographic airway abnormalities in untreated early rheumatoid arthritis are associated with peripheral neutrophil activation

    Background

    The role of the lung for the initiation and progression of rheumatoid arthritis (RA) is still unclear. Up to 10% of RA patients develop...

    Tilia Selldén, Carina Kärrman Mårdh, ... Anna-Karin Hultgård Ekwall in Arthritis Research & Therapy
    Article Open access 20 March 2023
  17. Imbalance of Th17, Treg, and helper innate lymphoid cell in the peripheral blood of patients with rheumatoid arthritis

    Introduction

    Rheumatoid arthritis (RA) is a chronic inflammatory disease involving a variety of immune cells, including adaptive T and B cells and...

    Ting Wang, **bing Rui, ... Xuefeng Wang in Clinical Rheumatology
    Article Open access 04 August 2022
  18. Baseline Anti-Citrullinated Protein Antibody Status and Response to Abatacept or Non-TNFi Biologic/Targeted-Synthetic DMARDs: US Observational Study of Patients with RA

    Introduction

    Patients with rheumatoid arthritis (RA) may respond to treatments differently based on their underlying serology and biomarker status,...

    Leslie R. Harrold, Sean E. Connolly, ... Vadim Khaychuk in Rheumatology and Therapy
    Article Open access 23 December 2021
  19. Serum rheumatoid factor IgA, anti-citrullinated peptide antibodies with secretory components, and anti-carbamylated protein antibodies associate with interstitial lung disease in rheumatoid arthritis

    Objective

    Rheumatoid arthritis (RA) is often complicated with chronic lung diseases (CLD), including interstitial lung disease (ILD) and airway...

    Shomi Oka, Takashi Higuchi, ... Shigeto Tohma in BMC Musculoskeletal Disorders
    Article Open access 13 January 2022
  20. Difficult to treat rheumatoid arthritis in a comprehensive evaluation program: frequency according to different objective evaluations

    Difficult-to-treat Rheumatoid Arthritis (RA-D2T) is a condition in which patients do not achieve the treatment target despite multiple advanced...

    Rodrigo Garcia-Salinas, Einer Sanchez-Prado, ... Sebastian Magri in Rheumatology International
    Article 03 June 2023
Did you find what you were looking for? Share feedback.